-
Semaglutide and Hair Loss Risk:A New Study Reveals Potential Issues
Semaglutide, a highly popular weight-loss drug, has gained widespread attention for its remarkable weight-loss effects and various health benefits. However, a recently published study indicates that the use of semaglutide may be associated with an increased risk of hair loss, particularly among women. This article will provide a detailed introduction to the background, methodology, results, and potential implications for clinical medication use of this study.
넶0 2025-03-27 -
A Record-Breaking Deal for a Domestic Weight-Loss Drug:The2 Billion Deal and Its Implications
This article delves into a landmark deal in the global pharmaceutical industry,where a domestic Chinese pharmaceutical company,Federal Pharmaceutical,has signed an exclusive licensing agreement with the multinational pharma giant Novo Nordisk.The deal involves a groundbreaking GLP-1 drug for weight loss and diabetes treatment,UBT251,with a potential value of up to2 billion.
넶8 2025-03-25
